Search
for
Sort by
Research 841–870 of 1000+
- Gleason grading controversies: what the chemoprevention trials have taught us
- Androgens and Antiandrogens influence on COVID-19 disease in men
- Germacrene Analogs are Anti-androgenic on Androgen-dependent Cells
- Novel Missense Mutation in the P-Box of Androgen Receptor in a Patient with Androgen Insensitivity Syndrome
- Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- The role of 5-alpha-reductase inhibitors in active surveillance
- Preparation of3H-labelled testosterone metabolites
- Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial
- Experimental Evaluation of 3-meta-Pyridine-1,2,4-Oxadiazole Derivative of Deoxycholic Acid as a Prototype of 5-α-Reductase Inhibitors in In Silico and In Vivo Models
- Allosteric interactions prime androgen receptor dimerization and activation
- Features of hyperandrogenism in men
- Finasteride in Androgenic Alopecia
- The finasteride riddle
- Effect of Exogenous Testosterone, Finasteride, and Castration on serum level of Thyroxin
- Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo
- Alopecia and the Aging Male
- Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
- Effection of Epristeride and Finasteride on Spermatogenesis in Male Rats
- Cyproterone Acetate: A Genotoxic Carcinogen?
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- Androgenic alopecia and its association with metabolic syndrome
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- Structural basis for the catalysis and inhibition of human steroid 5α‐reductase 2
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- Disorders in Male Sexual Differentiation Due to 5α-Reductase-2 Deficiency
- A clinicopathologic study of lichen planopilaris among men